Anne Uyttebroeck
-
- Lymphoma Diagnosis and Treatment 30
- Genetics top 2%
- Glioma Diagnosis and Treatment 22
- Hematology top 2%
- Acute Myeloid Leukemia Research 22
-
- Childhood Cancer Survivors' Quality of Life 41
- Oncology top 5%
-
- Acute Lymphoblastic Leukemia research 43
-
- Cancer-related cognitive impairment studies 17
-
- Family Support in Illness 14
-
- CNS Lymphoma Diagnosis and Treatment 11
- Co-authors
- Marleen RenardPeter VandenbergheJan CoolsJózsef ZsírosSabine DeprezCharlotte SleursKim De KeersmaeckerJurgen Lemiere
- Journals
- New England Journal of Medicine (1 paper)Journal of Clinical Oncology (5 papers)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- BelgiumNetherlandsFrance
In The Last Decade
Anne Uyttebroeck
122 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 100
- Pathology and Forensic Medicine 891
- Genetics 398
- Hematology 402
- Pediatrics, Perinatology and Child Health 662
- Oncology 734
Countries citing papers authored by Anne Uyttebroeck
This map shows the geographic impact of Anne Uyttebroeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Uyttebroeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Uyttebroeck more than expected).
Fields of papers citing papers by Anne Uyttebroeck
This network shows the impact of papers produced by Anne Uyttebroeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Uyttebroeck. The network helps show where Anne Uyttebroeck may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Anne Uyttebroeck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 7 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 4 | |
| 8 | 2023 | 4 | |
| 9 | 2022 | 2 | |
| 10 | 2022 | 5 | |
| 11 | 2021 | 10 | |
| 12 | 2021 | 9 | |
| 13 | 2021 | 7 | |
| 14 | 2020 | 21 | |
| 15 | 2020 | 47 | |
| 16 | 2019 | 23 | |
| 17 | 2018 | 23 | |
| 18 | 2018 | 63 | |
| 19 | 2016 | 40 | |
| 20 | Dexamethasone (DEX) versus prednisone (PRED) in T-cell non Hodgkin lymphoma (T-NHL): results of the randomized phase III trial 58951 of the EORTC Children Leukemia Group | 2012 | 6 |
About Anne Uyttebroeck
Anne Uyttebroeck is a scholar working on Genetics, Pediatrics, Perinatology and Child Health and Hematology, having authored 132 papers that have together received 2.7k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (43 papers), Childhood Cancer Survivors' Quality of Life (41 papers), Lymphoma Diagnosis and Treatment (30 papers), Glioma Diagnosis and Treatment (22 papers), Acute Myeloid Leukemia Research (22 papers), Cancer-related cognitive impairment studies (17 papers), Family Support in Illness (14 papers) and CNS Lymphoma Diagnosis and Treatment (11 papers). The work is most often cited by research in Pathology and Forensic Medicine (891 citations), Genetics (398 citations) and Hematology (402 citations). Anne Uyttebroeck has collaborated with scholars based in Belgium, Netherlands and France. Frequent co-authors include Marleen Renard, Peter Vandenberghe, Jan Cools, József Zsíros, Sabine Deprez, Charlotte Sleurs, Kim De Keersmaecker, Jurgen Lemiere, Javier Gáname and Bart Bijnens. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.